Nutrition in End-Stage Renal Disease

Chronic Kidney Disease, Dialysis, & Transplantation

Volumn , Issue , 2005, Pages 214-231

  Masud, Tahsin ^a   Mitch, William E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60649085217     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0158-4.50015-X     Document Type: Chapter

References (216)

1. Excerpts from the USRDS 2002 Annual DataReport: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 2003, (suppl 2):S1-S260. U.S. Renal Data Systems, 41.
2. Lowrie EG, Lew NL Death risk in hemodialysis patients: the predictive value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 1990, 15:458.
3. Avram MM, Goldwasser P, Errora M, et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic parameters. Am J Kidney Dis 1994, 23:91.
4. Mitch WE Malnutrition: a frequent misdiagnosis for hemodialysis patients. J. Clin. Invest 2002, 110:437.
5. Bergstorm J, Lindholm B What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?. Seminars in Dialysis 2000, 13:163-164.
6. Kaysen GA Biological basis of hypo-albuminemia in ESRD. J. Am. Soc. Nephrol 1998, 9:2368-2376.
7. Stenvinkle P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1899.
8. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesrolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998, 32:107-114.
9. Kaysen GA, Dubin JA, Muller HG, Mitch WE, et al. Levels of alpha1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients. Kidney Int 2001, 60:2360.
10. Walser M, Hill S Can renal replacement be deferred by a supplemented very low protein diet?. J Am Soc Nephrol 1999, 10:110.
11. Aparicio M, Chauveau P, De Precigout V, et al. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 2000, 11:708.
12. Qureshi AR, Alverstand A, Danielsson A, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998, 53:773-782.
13. Pereira BJ, Shapiro L, King AJ, et al. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994, 45:890-896.
14. Caglar K, Peng Y, Pupim L., et al. Inflammatory signals associated with hemodialysis. Kidney Int 2002, 62:1408-1416.
15. Yeh S-S, Schuster MW Geriatric cachexia: the role of cytokines. Am J Clin Nutr 1999, 70:183-197.
16. McMurray J, Abdullah I, Dargie H, et al. Increased concentration of tumor necrosis factor in cachetic patients with severe chronic heart failure. Br Heart J 1991, 66:356-358.
17. Tan KB, Chow WS, Tam SC, et al. Atrovastatin lowers C-reactive protein and improves endothelium-dependent vasodilatation in type 2 diabetes mellitus. J Clin Endocrinol Metab 2002, 87:563-568.
18. Pereira BJ, Shapiro L, King AJ, et al. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int. 1994, 45:890-896.
19. Hakim RM, Breillatt J, Lazarus JM, et al. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984, 311:878-882.
20. Goodman MN Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am. J. Physiol 1991, 260:E727-E730.
21. May RC, Bailey JL, Mitch WE, Masud T, et al. Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int 1996, 49:679-683.
22. Tiao G., et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest. 1996, 97:339-348.
23. Du J, Mitch WE, Wang X, and Price SR. Glucocorticoids induce proteasome C3 subunit expression in L6 muscle cells by opposing the suppression of its transcription by NF-kB. J. Biol. Chem 200; 275:19661-19666.
24. Mitch WE, Price SR Transcription factors and muscle cachexia: have we defined a therapeutic target?. Lancet 2001, 357:734-735.
25. Hara Y, May RC, Kelly RA, Mitch WE Acidosis, not azotemia, stimulates branched-chain amino acid catabolism in uremic rats. Kidney Int 1987, 32:808-814.
26. Bailey JL, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J. Clin. Invest 1996, 97:1447-1453.
27. Mitch WE, Goldberg AL Mechanisms of muscle wasting: the role of the ubiquitin-proteasome system. N. Engl. J. Med 1996, 335:1897-1905.
28. Pickering WP, Price SR, Bircher G, et al. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 2002, 61:1286-1292.
29. Ballmer PE, McNurlan MA, Hulter HN, et al. Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. J. Clin. Invest 1995, 95:39-45.
30. Movilli E, Zani R, Carli O, et al. Correction of metabolic acidosis increases serum albumin concentration and decreases kinetically evaluated protein intake in hemodialysis patients: a prospective study. Nephrol. Dial. Transplant 1998, 13:1719-1722. 1998.
31. Price SR, Bailey J, Wang X, et al. Muscle wasting in insulino-penic rats results from activation of the ATP-dependent, ubiquitin-proteasome pathway by a mechanism including gene transcription. J. Clin. Invest 1996, 98:1703-1708.
32. Mitch WE, Bailey J, Wang X, et al. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol 1999, 276:C1132-C1138.
33. Tiao G, Fagan J, Roegner V, et al. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest 1996, 97:339-348.
34. Wing SS, Goldberg AL Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol 1993, 264:E668-E676.
35. DeFronzo RA, Tobin JD, Rowe JW, et al. Glucose intolerance in uremia. J Clin Invest. 1978, 62:425-430.
36. Guiterrez A, Bergstrom J, Alvestrand A Hemodialysis-associated protein catabolism with and without glucose in the dialysis fluid. Kidney Int 1994, 46:814-822.
37. Hakim RM, Lazarus JM Biochemical parameters in chronic renal failure. Am. J. Kidney Dis 1988, 9:238-247.
38. Anderstam B, Mamoun AH, Bergstrom J, et al. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J. Am. Soc. Nephrol 1996, 7:2453-2460.
39. Ikizler TA, Pupim L, Brouillette JR, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am. J. Physiol 2002, 282:E107-E116.
40. Thunberg BJ, Swamy AP, Cestero RVM Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 1981, 34:2005-2012.
41. Schoenfeld PY, Henry RR, Laird NM, et al. Assessment of nutritional status of the National Cooperative Dialysis Study population. Kidney Int 1983, 23(suppl 13):80-88.
42. Marckmann P Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 1998, 29:75-78.
43. Enia G, Sicuso C, Alati G, et al. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993, 8:1094-1098.
44. Cianciaruso B, Brunori G, Kopple JD, et al. Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patients. Am J Kidney Dis 1995, 26:475-486.
45. Tai TW, Chan AM, Cochran CC, et al. Renal dietitians' perspective: identification, prevalence, and intervention for malnutrition in dialysis patients in Texas. J Ren Nutr 1998, 8:188-198.
46. Mancini A, Grandaliano G, Magarelli P, et al. Nutritional status in hemodialysis patients and bioimpedance vector analysis. J Ren Nutr 2003, 3:199-204.
47. Rocco MV, Paranandi L, Burrowes JD, et al. Nutritional status in the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis 2002, 39:245-256.
48. Bergstörm J Why are the dialysis patients malnourished?. Am J Kidney Dis 1995, 26:229-241.
49. Bergstörm J, Fürst P, Alvestrand A, et al. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continous ambulatory peritoneal dialysis. Kidney Int 1993, 44:1048-1057.
50. Lindsay RM, Spanner E A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dia-lyzed uremic patients. Am J Kidney Dis 1989, 13:382-389.
51. Goodship THJ, Passlick-Deetjen J, Ward MK, et al. Adequacy of dialysis and nutritional status in CAPD. Nephrol Dial Transplant 1993, 8:1366-1371.
52. Aguilera A, Selgas R, Codoceo R, Bajo A Uremic Anorexia: A consequence of persistently high brain serotonin levels? The Tryptophan/Serotonin disorder hypothesis. Perit Dial Int 2000, 20:810-816.
53. Slomowitz LA, Monteon FJ, Grosvenor M, et al. Effects of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 1989, 35(704):711.
54. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 2000, 6(suppl 2):S1-S140. National Kidney Foundation.
55. Lorenzo V, deBonis E, Rufino M, et al. Caloric rather than protein deficiency predominates in stable chronic hemodialysis patients. Nephrol Dial Transplant 1995, 10:1885-1889.
56. Burrows JD, Larive B, Cockram DB, et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis days in hemodialysis patients: Cross-sectional results from HEMO study. J Renal Nutr 2003, 13:191-198.
57. Chazot C, Shahmir E, Matias B, et al. Dialytic nutrition: Provision of amino acids in dialysate during hemodialysis. Kidney Int 1997, 52:1663-1670.
58. Wolfson M, Jones MR, Kopple JD Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 1986, 21:500-506.
59. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM Amino acid and albumin losses during hemodialysis. Kidney Int 1994, 46:830-837.
60. Kopple JD, Swendseid ME, Shinaberger JH, Umezawa CY The free and bound amino acids removed by hemodialysis. ASAIO Trans 1973, 19:309-313.
61. Kaplan AA, Halley SE, Lapkin RA, et al. Dialysate protein losses with processed polysulphone dialysers. Kidney Int 1995, 47:573-578.
62. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW Protein losses during peritoneal dialysis. Kidney Int 1981, 19:593-602.
63. Ikizler TA, Hakim RM Nutrition in end-satge renal disese. Kidney Int 1996, 50:343-357.
64. Kopple JD, Blumenkrantz MJ, Jones MR, et al. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1982, 36:395-402.
65. Kopple JD The National Kidney Foundation K/DOQI clinical guidelines for dietary protein intake for chronic dialysis patients. Am J Kidney Dis 2001, 38(Suppl 4):S68-S73.
66. Neyra R, Chen KY, Sun M, et al. Increased resting energy expenditure in patients with end-stage renal disease. J Parenter Enteral Nutr 2003, 27:36-42.
67. Ikizler TA, Wingard RL, Sun M, et al. Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol. 1996, 7:2646-2653.
68. Kopple JD Dietary protein and energy requirements in ESRD patients. Am J Kidney Dis 1998, 32(6 Suppl 4):S97-104.
69. Monteon FJ, Laidlaw SA, Shaib JK, et al. Energy expenditure in patients with chronic renal failure. Kidney Int 1986, 30:741-747.
70. Umeakunne K Approaches to successful nutrition intervention in renal disease. Handbook of Nutrition and Kidney 2002, 292-325. Lippincott Williams and Wilkins, Philadelphia. 4 th Ed. W.E. Mitch, S. Klahr (Eds.).
71. Vychytil A, Horl WH Nutrition and peritoneal dialysis. Handbook of Nutrition and Kidney 2002, 233-271. Lippincott Williams and Wilkins, Philadelphia. 4 th Ed. W.E. Mitch, S. Klahr (Eds.).
72. Depner TA Quantification of dialysis. Urea modeling: the basics. Semin Dial 1991, 4:179-184.
73. Depner TA, Cheer A Modeling urea kinetics with two vs. three BUN measurements. A critical comparison. J ASAIO Trans 1989, 35:499-502.
74. K/DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 2000, 37:S15-S26. National Kidney Foundation.
75. Depner TA, Daugirdas JT Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 1996, 7:780-785.
76. Bergstorm J, Heimburger O, Lindholm B Calculation of the protein equivalent of total nitrogen appearance and total nitrogen appearance in chronic renal failure and CAPD patients. Which formula should be used?. Perit Dial Int 1998, 18:467-473.
77. Randerson DH, Chapman GV, Farrell PC Amino acids and dietary status in CAPD patients. Peritoneal Dialysis 1981, 179-191. Churchill Livingstone, Edinburough, UK. R.C. Atkins, N.M. Thomson, P.C. Farrell (Eds.).
78. Panzetta G, Tessitore N, Faccini G, et al. The protein catabolic rate as a measure of protein intake in dialysis patients: Usefulness and limits. Nephrol Dial Transplant 1990, 5(suppl 1):S125-S127.
79. Mittman N, Avram MM, Oo KK, et al. Serum prealbimin predicts survival in hemodialysis and peritoneal dialysis: 10 Years of propective observation. Am J Kidney Dis 2001, 38:1358-1364.
80. Neyra NR, Hakim RM, Shyr Y, et al. J Renal Nutr 2000, 10:184-190.
81. Cano N, Di Costanzo-Dufetel J, Calaf R, et al. Prealbumin-reti-nal-binding-protein-retinol complex in hemodialysis patients. Am J Clin Nutr 1988, 47:664-667.
82. Kopple JD, Swendseid ME Protein and amino acid metabolism in uremic patients undergoing maintenance hemodialysis. Kidney Int Suppl 1975, 2:S64-S72.
83. Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol. 1997, 8:632-637.
84. Uribarri J Moderate metaboic acidosis and its effects on nutritional parameters in hemodialysis patients. Clin Nephrol 1997, 48:238-240.
85. Kirschbaum BB Spurious Metabolic Acidosis in hemodialysis patients. Am J Kidney Dis 2000, 35:1068-1071.
86. Stein A, Moorhouse J, Iles-Smith H, et al. Role of an improvement in acid-base stats and nutrition in CAPD patietns. Kidney Int 1997, 52:1089-1095.
87. Szeto CC, Wong TY, Chow KM, et al. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003, 14:2119-2126.
88. Duerksen DR, Papineau N Electrolyte abnormalities in patients with chronic renal failure receiving parenteral nutrition. J Parenter Enteral Nutr 1998, 22:102-104.
89. Newman LN, Weiss MF, Berger J, et al. The law of unintended consequences in action: increase in incidence of hypokalemia with improved adequacy of dialysis. Adv Perit Dial. 2000, 16:134-137.
90. Blumenkrantz MJ, Kopple JD, Gutman RA, et al. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980, 33:1567-1585.
91. Borovnicar DJ, Wong KC, Kerr PG, et al. Total body protein status assessed by different estimates of fat-free mass in adult peritonea dialysis patients. Eur J Clin Nutr 1996, 50:607-616.
92. Avram MM, Bonomini LV, Sreedhara R, et al. Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years. Am J Kidney Dis. 1996, 28:910-917.
93. Hans DS, Lee SW, Kang SW, et al. Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 1996, 12:288-292.
94. Goldwasser P, Kaldas AI, Barth RH Rise in serum albumin and creatinine in the first half year on hemodialysis. Kidney Int. 1999, 56:2260-2268.
95. Lowrie EG, Haung WH, Lew NL Death risk predictors among peritoneal and hemodialysis patients. A preliminary comparison. Am J Kidney Dis 1995, 26:220-228.
96. Avram MM, Mittman N, Bonomini L, et al. Markers for survival in dialysis.: A seven-year prospective study. Am J Kidney Dis 1995, 26:209-219.
97. Iseki K, Miyasato F, Tokuyama K, et al. Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 1997, 51:1212-1217.
98. Piccoli GB, Quarello F, Salomone M, et al. Are serum albumin and cholesterol reliable outcome markers in elderly dialysis patients?. Nephrol Dial Transplant 1995, 10(suppl 6):S72-S75.
99. Port FK, Ashby VB, Dhingra RK, et al. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002, 13:1061-1066.
100. Leavey SF, McCullough K, Hecking E, et al. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001, 16:2386-2394.
101. Wolfe RA, Ashby VB, Daugirdas JT, et al. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis. 2000, 35:80-88.
102. Nelson EE, Hong CD, Pesce AL, et al. Anthropometric norms for the dialysis patient population. Am J Kidney Dis 1990, 16:32-37.
103. Chumlea WC, Dwyer J, Bergen C, et al. Nutritional status assessed from anthropometric measures in the HEMO study. J Renal Nutr 2003, 13:31-38.
104. Allon M, Depner TA, Radeva M, et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol. 2003, 14:1863-1870.
105. Keshaviah P Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994, 4:1475-1485.
106. Bhatla B, Moore H, Emerson P, et al. Lean body mass estimation by creatinine kinetics, bioimpedence, dual energy x-ray absorptiometry in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1995, 41:M442-M446.
107. Szeto CC, Kong J, Wu AKL, et al. The role of lean body mass as a nutritional index in chinese peritoneal dialysis patients-comparison of creatinine kinetics method and anthrpometric method. Perit Dial Int 2000, 20:708-714.
108. Johansson AC, Attmen PO Haraldsson B. Creatinine generation rate and lean body mass: a critical analysis in peritoneal dialysis patients. Kidney Int 1997, 51:855-859.
109. Heimburger O, Qureshi AR, Blaner WS, et al. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000, 36:1213-1225.
110. Young GA, Kopple JD, Lindholm B, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 1991, 17:462-471.
111. Enia G, Sicuso C, Alati G, Zoccali C Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993, 8:1094-1098.
112. McCusker FX, Teehan BP, Thorpe KE, et al. How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int 1996, 50(suppl56):S56-S61.
113. Cooper BA, Bartlett LH, Aslani A, et al. Validity of subjective global assessment as a nutritional marker in end-stage renal disease. Am J Kidney Dis. 2002, 40:126-132.
114. Goldstein-Fuchs DJ Assesment of nutritional status in renal diseases. Handbook of Nutrition and Kidney 2002, 233-271. Lippincott Williams and Wilkins, Philadelphia. 4 th Ed. W.E. Mitch, S. Klahr (Eds.).
115. Maroni BJ, Mitch WE Role of nutrition in prevention of the progression of renal disease. Ann Rev Nutr 1997, 17:435-455.
116. Brouhard BH, LaGrone L Effect of dietary protein restriction on functional renal reserve in diabetic nephropathy. Am J Med 1990, 89:427-431.
117. Zeller KR, Whittaker E, Sullivan L, Raskin P, Jacobson HR Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991, 324:78-83.
118. Dullaart RP, Beusekamp BJ, Meijer S, van Doormaal JJ, Sluiter WJ Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care 1993, 16:483-492.
119. Raal FJ, Kalk WJ, Lawson M, Esser JD, Buys R, Fourie L, et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: A 6-mo prospective study. Am J Clin Nutr 1994, 60:579-585.
120. Fouque D, Laville M, Boissel JP, Chifflet R, Labeeuw M, Zech PY Controlled low protein diets in chronic renal insufficiency: meta-analysis. Br Med J 1992, 304:216-220.
121. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis. Ann Intern Med 1996, 124:627-632.
122. Fouque D, Wang P, Laville M, Boissel JP Low protein diets delay end-stage renal disease in non diabetic adults with chronic renal failure. Nephrol Dial Transpl 2000, 15:1986-1992.
123. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker LJ, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal failure. N Engl J Med 1994, 330:878-884.
124. Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kid Dis 1996, 27:652-663.
125. Taal MW, Brenner BM Renoprotective benefits of RAS inhibition: From ACEI to antiotensin II antagonists. Kidney Int 2000, 57:1803-1817.
126. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 1995, 47:1703-1720. DCCT Research Group.
127. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994, 331:1194-1199.
128. Ikizler TA, Greene JH, Wingard RL, et al. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 1995, 6:1386. 1391.
129. Hakim RM, Lazarus JM Initiation of dialysis. J Am Soc Nephrol 1995, 6:1319. 1320.
130. Lowrie EG, Lew NL Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of the death rate differences among facilities. Am J Kidney Dis. 1990, 15:458. 482.
131. Kaysen GA Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 1998, 9:2368-2376.
132. Walser M Does prolonged protein restriction preceding dialysis lead to protein malnutrition at the onset of dialysis?. Kidney Int 1993, 44:1139-1144.
133. Aparicio M, Chauveau P, Precigout VD, et al. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 2000, 11:708-716.
134. Coresh J, Walser M, Hill S Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis. J Am Soc Nephrol 1995, 6:1379-1385.
135. Masud T, Young VR, Chapman T, Maroni BJ: Adaptive responses to very low protein diets: The first comparison of ketoacids to essential amino acids. Kidney Int 45:1182-1192.
136. Tom K, Young VR, Chapman T, Masud T, Akpele L, Maroni BJ Long-term adaptive responses to dietary protein restriction in chronic renal failure. Am J Physiol 1995, 268:E668-E677.
137. Bernhard J, Beaufrere B, Laville M, Fouque D Adaptive response to a low-protein diet in predialysis chronic renal failure patients. J Am Soc Nephrol. 2001, 12:1249-1254.
138. Vendrely B, Chauveau P, Barthe N, et al. Nutrition in hemodialysis patients previously on a supplemented very low protein diet. Kidney Int 2003, 63:1491-1498.
139. K/DOQI Clinical Practice Guidelines For Peritoneal Dialysis Adequacy. Am J Kidney Dis 2000, 37:S65-S136. National Kidney Foundation.
140. Pollock CA Protein intake in renal disease. J Am Soc Nephrol 1997, 8:777-783.
141. Churchill DN, Taylor DW, Keshaviah PR, et al. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996, 7:198-207.
142. Bonmini V, Feletti C, Scolari MP, et al. Benefits of early initiation of dialysis. Kidney Int 1985, 28(Suppl 17):S57-S59.
143. Bergman JM, Thorpe KE, Churchill DN Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001, 12:2158-2162.
144. Termorshuizen F, Korevaar JC, Dekker FW, et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: An analysis of the netherlands cooperative study on the adequacy of dialysis (Necosad)-2. Am J Kidney Dis. 2003, 41:1293-1302.
145. Korevaar JC, Jansen M, Dekker FW, et al. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet 2001, 358:1046-1050.
146. Traynor JP, Simpson K, Geddes C, et al. Early Initiation of Dialysis Fails to Prolong Survival in Patients with End-Stage Renal Failure. J Am Soc Nephrol 2002, 13:2125-2132.
147. Beddhu S, Samove MH, Roberts MS, Stoddard GL, Ramkinmar N, Pappas LM, Cheung AK Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol 2003, 14:2305-2312.
148. Korevaar JC, Jansen MAM, Dekker FW, et al. Evaluation of DOQI guidelines: early start of dialysis treatment is not associated with better health-related quality of life. Am J Kidney Dis. 2002, 39:108-115.
149. Mitch WE Mechanisms causing loss of lean body mass in kidney disease. Am J Clin Nutr 1998, 67:359-365.
150. Kopple JD Therapeutic approaches to malnutrition in chronic dialysis patients: The different modalities of nutritional support. Am J Kidney Dis. 1999, 33:180-185.
151. Ginn H, Frost A, Lacy W Nitrogen balance in hemodialysis patients. Amer J Clin Nutr 1968, 21:385-393.
152. Borah M, Schoenfeld PY, Gotch FA, et al. Nitrogen balance in intermittent hemodialysis therapy. Kidney Int 1978, 14:491-500.
153. Ikizler TA, Greene JH, Yenicesu M, Schulman G, Wingard RL, Hakim RM Nitrogen balance in hospitalized chronic hemodialysis patients. Kidney Int 1996, 50(suppl 57):S53-S56.
154. Rao M, Sharma M, Juneja R, et al. Calculated nitrogen balance in hemodialysis patients: Influence of protein intake. Kidney Int 2000, 58:336-345.
155. Uribarri J DOQI guidelines for nutrition in long-term peritoneal dialysis patient: A dissenting view. Am J Kidney Dis 2001, 37:1313-1318.
156. 4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12:2131-2138.
157. Block GA, Port FK Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 2000, 35:1226-1237.
158. K/DOQI guidelines for Bone Metabolism and Diseases in Chronic Kidne Disease. Am J Kidney 2003, 42(suppl3):S62-S83. National Kidney Foundation.
159. Maroni BJ Requirements for protein, calories, and fat in the predialysis patient. Handbook of Nutrition and the Kidney 1998, 144-165. Lippincott-Raven, Philadelphia. 3nd ed. W.E. Mitch, S. Klahr (Eds.).
160. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker LJ, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal failure. N Engl J Med 1994, 330:878-884.
161. Mitch WE, Wilcox CS Disorders of body fluids, sodium and potassium in chronic renal failure. Am J Med 1982, 72:536-550.
162. Westhuzen J Folate supplementation in the dialysis patient-fragmantary evidence and tentative recommendations. Nephron Dial Transplant 1998, 13:2748-2750.
163. Yousuf S, Dagenais G, Pogue, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Oucome Prevention Evaluation Study Inveestigators. N Engl J Med 2000, 342:154-160.
164. Masud T Trace elements and vitamins in renal disease. Handbook of Nutrition and the Kidney 2002, 233-252. Lippincott Williams and Wilkins, Philadelphia. 4 th ed,. W.E. Mitch, S. Klahr (Eds.).
165. Chertow GM, Christiansen CL, Cleary PD, et al. Prognostic stratification in critically ill patients whith acute renal failure requiring dialysis. Arch Intern Med 1995, 155:1505-1511.
166. Brivet FG, Kleinknecht DJ, Loirat P, et al. The French Study Group on Acute Renal Failure Acute renal failure in intensive care units. Causes, outcome and prognostic factors of hospital mortality; a prospective, multicenter study. Crit Care Med 1996, 24:192-198.
167. Tonelli M, Manns B, Feller-Kopman D Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis. 2002, 40:875-885.
168. Sponsel H, Conger JD Is parenteral nutrition therapy of value in acute renal failure?. Am J Kidney Dis 1995, 25:96-102.
169. Druml W Nutritional management of acute renal failure. Am J Kidney Dis. 2001, 37(Suppl 2):S89-S94.
170. Mitch WE Amino acid release from the hindquarter and urea appearance in acute uremia. Am J Physiol 1981, 241:E415-E419.
171. Salusky I, Flugel-Link R, Jones M, et al. Effect of acute uremia on protein degradation and amino acid release in the rat hemi-corpus. Kidney Int 1983, 24(Suppl 16):S43-S47.
172. Abel R, Beck C, Abbot W, et al. Improved survival from acute renal failure after treatment with intravenous essential a-amino acids and glucose. N Engl J Med 1973, 288:695-699.
173. Baek S, Makaboli G, Bryan-Brown C, et al. The influence of parenteral nutrition on the course of acute renal failure. Surg Gynecol Obstet 1975, 141:405-408.
174. Pelosi G, Proitti R, Arcangeli A, et al. Total parenteral infusate, an approach to its optimal composition in post trauma acute renal failure. Resuscitation 1981, 9:45-51.
175. Fienstein EI, Blumenbrantz M, Healy M, et al. Clinical and metabolic responses to parenteral nutroition in acute renal failure. Medicine 1981, 60:124-137.
176. Druml W Nutritional support in acute renal failure. Handbook of Nutrition and Kidney 2002, 273-291. Lippincott Williams and Wilkins, Philadelphia. 4 th Ed. W.E. Mitch, S. Klahr (Eds.).
177. Macias WL, Alaka KJ, Murphy MH, et al. Impact of nutritional regimen on protein catabolism and nitrogn balance in patients with acute renal failure. J Parenter Enteral Nutr 1996, 20:56-62.
178. Davies SP, Reaveley DA, Brown EA, Kox WJ Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med 1991, 19:1510-1515.
179. Davenport A, Roberts NB Amino acid losses during continuous high-flux hemofiltration in the critically ill patient. Crit Care Med 1989, 17:1010-1015.
180. Bertolatus JA Nutritional requirements of renal transplant patients. Handbook of Nutrition and Kidney 2002, 273-291. Lippincott Williams and Wilkins, Philadelphia. 4 th Ed. W.E. Mitch, S. Klahr (Eds.).
181. Whittier FC, Evans DH, Dutton S Nutrition in renal transplantation. Am J Kidney Dis 1985, 6:405-411.
182. Windus DW, Lacson S, Delmez JA The short-term effects of a low-protein diet in stable renal transplant recipients. Am J Kidney Dis. 1991, 17:693-699.
183. Bernardi A, Biasia F, Pati T, et al. Long-term protein intake control in kidney transplant recipients: effect in kidney graft function and in nutritional status. Am J Kidney Dis. 2003, 41(3 Suppl 1):S146-S152.
184. Salahudeen AK, Hostetter TH, Raatz SK, et al. Effects of dietary protein in patients with chronic renal transplant rejection. Kidney Int. 1992, 41:183-190.
185. Johnson DW, Isbel NM, Brown AM, et al. The effect of obesity on renal transplant outcomes. Transplantation 2002, 74:675-681.
186. Baum CL, Thielke K, Westin E, et al. Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition 2002, 18:139-146.
187. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.7. Cardiovascular risks. Obesity and weight gain. Nephrol Dial Transplant 2002, 17(Suppl 4):29-30. EBPG Expert Group on Renal Transplantation.
188. Meier-Kriesche HU, Arndorfer JA, et al. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 2002, 73:70-74.
189. Moore RA, Callahan MF, Cody M, et al. The effect of the American Heart Association step one diet on hyperlipidemia following renal transplantation. Transplantation 1990, 49:60-62.
190. Caravaca F, Fernandez MA, Ruiz-Calero R, et al. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients. Nephrol Dial Transplant 1998, 13:2605-2611.
191. Reinhardt W, Bartelworth H, Jockenhovel F, et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 1998, 13:436-442.
192. Higgins RM, Richardson AJ, Endre ZH, et al. Hypophosphatemia after renal transplantation: relationship to immunosuppressive drug therapy and effects on muscle detected by 31P nuclear magnetic resonance spectroscopy. Nephrol Dial Transplant 1990, 5:62-68.
193. Caglar K, Fedje L, Dimmitt R, Hakim RM, et al. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int. 2002, 62:1054-1059.
194. Pate MG, Kitchen S, Miligan PJ The effect of dietary supplements on the nPCR in stable hemodialysis patient. J Renal Nutr. 2000, 10:69-75.
195. Stieber AL, Handu DJ, Cataline Dr, et al. The impact of nutrition intervention on a reliable morbidity and mortality indicator: the hemodialysis-prognostic nutrition index. J Renal Nutr. 2003, 13:186-190.
196. Kuizon BD, Nelson PA, Salusky IB Tube feeding in children with end-stage renal disease. Miner Electrolyte Metab 1997, 23:306-310.
197. Cherry N, Shalansky K Efficacy of intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Health Sys Pharm. 2002, 15:1736-1741.
198. Capelli JP, Kushner H, Camiscioli TC, et al. Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis. 1994, 23:808-816.
199. Foulks C An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 1999, 33:186-192.
200. Pupim LB, Flakoll PJ, Brouillette JR, et al. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest 2002, 110:483-492.
201. Kopple JD, Foulks CJ, Piraino B, et al. Proposed Health Care Financing Administration guidelines for reimbursement of enteral and parenteral nutrition. Am J Kidney Dis. 1995, 26:995-997.
202. Lukaski HC Validation of body composition assessment techniques in the dialysis population. ASAIO J. 1997, 43(3):251-255.
203. Dumler F, Kilates C Body composition analysis by bioelectrical impedance in chronic maintenance dialysis patients: comparisons to the National Health and Nutrition Examination Survey III. J Ren Nutr. 2003, 13:166-172.
204. Dumler F, Kilates C Use of bioelectrical impedance techniques for monitoring nutritional status in patients on maintenance dialysis. J Ren Nutr. 2000, 10:116-124.
205. Stenver DI, Gotfredsen A, Hilsted J, et al. Body composition in hemodialysis patients measured by dual-energy X-ray absorptiometry. Am J Nephrol. 1995, 15:105-110.
206. Konings CJ, Kooman JP, Schonck M, et al. Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int. 2003, 23:184-190.
207. Stall S, DeVita MV, Ginsberg NS, et al. Body composition assessed by neutron activation analysis in dialysis patients. Ann N Y Acad Sci. 2000, 904:558-563.
208. Cooper BA, Aslani A, Ryan M, et al. Comparing different methods of assessing body composition in end-stage renal failure. Kidney Int. 2000, 58:408-416.
209. Kamyar Kalantar-Zadeh, Gladys Block, et al. Near infra-red interactance for longitudinal assessment of nutrition in dialysis patients. J Ren Nutr 2001, 11:23-31.
210. Junger P, Chauveau P, Ployard F, et al. Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney Int 1987, 32(suppl 22):S67-S71.
211. Bergstörm J, Alvestrand A, Bucht H, et al. Stockholm clinical study on progression of chronic renal failure_An interim report. Kidney Int 1989, 36(suppl 27):S110-S114.
212. Ihle BU, Becker GJ, Whitworth JA, et al. The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 1989, 321:1773-1777.
213. Rosman JB, Langer K, Brandl M, et al. Protein-restricted diets in chronic renal failure: A four year follow-up shows limited indications. Kidney Int 1989, 27:S96-S102.
214. Locatelli F, Alberti D, Graziani G, et al. Propective randomized, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. North Italian Cooperative Study Group. Lancet 1991, 337:1299-1304.
215. Williams PS, Stevens ME, Fass G, et al. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: A prospective, randomized, controlled trial. Q J Med 1991, 81:837-855.
216. D'Amico G, Gentile MG, Fellin G, et al. Effect of dietary protein restriction on the progression of renal failure: A prospective randomized trial. Nephrol Dial Transplant 1994, 9:1590-1594.